In humans as well as mice, tryptophan supplementation has been found to elevate plasma levels of tryptophan metabolites, KYN, and KYNA (95) therefore, it is clinically relevant to understand the role of tryptophan supplementation on organ ACE2 levels, and its relation to COVID-19 susceptibility. The gene discussed is ACE2; the disease is COVID-19.